Towards a new age in the treatment of multiple myeloma
Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-γ agonists induced apoptosis in human monocyte leukemia cells in vitro
Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes
Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia
Genetic variation of FUT2 in a Ghanaian population
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates
Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin
Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions
Thrombotic thrombocytopenic purpura as the initial presentation of Pneumocystis jiroveci pneumonia in an immunocompetent patient
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura
Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome
Intensive blood transfusion support in acquired hemophilia A
Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib